195rar Review

In a study published in , scientists investigated a protein called SYK (Spleen Tyrosine Kinase). They knew SYK was present in blood cancers but weren't sure exactly how it contributed to the disease. They discovered that SYK acts as a "partner in crime" with another protein called FLT3 , which is frequently mutated in leukemia patients. The 195RAR Mutation

Because this specific interaction is so vital for the cancer to progress, it identified a new potential "weak spot" that future drugs could target to treat AML more effectively. 195rar

By changing a specific sequence of amino acids from to GAL , researchers created a mutant version of the protein. In a study published in , scientists investigated